These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Assessment of safety and feasibility of non-invasive vagus nerve stimulation for treatment of acute stroke. Arsava EM; Topcuoglu MA; Ay I; Ozdemir AO; Gungor IL; Togay Isikay C; Nazliel B; Kozak HH; Ozturk S; Yilmaz İA; Dora B; Ay H; Brain Stimul; 2022; 15(6):1467-1474. PubMed ID: 36356829 [TBL] [Abstract][Full Text] [Related]
24. A Randomized Sham-Controlled Cross-Over Study on the Short-Term Effect of Non-Invasive Cervical Vagus Nerve Stimulation on Spinal and Supraspinal Nociception in Healthy Subjects. Alt LK; Wach K; Liebler EJ; Straube A; Ruscheweyh R Headache; 2020 Sep; 60(8):1616-1631. PubMed ID: 32592516 [TBL] [Abstract][Full Text] [Related]
25. Migraine treatment with external concurrent occipital and trigeminal neurostimulation-A randomized controlled trial. Tepper SJ; Grosberg B; Daniel O; Kuruvilla DE; Vainstein G; Deutsch L; Sharon R Headache; 2022 Sep; 62(8):989-1001. PubMed ID: 35748757 [TBL] [Abstract][Full Text] [Related]
26. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569 [TBL] [Abstract][Full Text] [Related]
27. External Concurrent Occipital and Trigeminal Neurostimulation Relieves Migraine Headache: A Prospective, Randomized, Double-Blind, Sham-Controlled Trial. Daniel O; Tepper SJ; Deutsch L; Sharon R Pain Ther; 2022 Sep; 11(3):907-922. PubMed ID: 35661128 [TBL] [Abstract][Full Text] [Related]
28. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lipton RB; Dodick DW; Silberstein SD; Saper JR; Aurora SK; Pearlman SH; Fischell RE; Ruppel PL; Goadsby PJ Lancet Neurol; 2010 Apr; 9(4):373-80. PubMed ID: 20206581 [TBL] [Abstract][Full Text] [Related]
29. Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study. Grazzi L; Egeo G; Calhoun AH; McClure CK; Liebler E; Barbanti P J Headache Pain; 2016 Dec; 17(1):91. PubMed ID: 27699586 [TBL] [Abstract][Full Text] [Related]
30. Effects of non-invasive vagus nerve stimulation on attack frequency over time and expanded response rates in patients with chronic cluster headache: a post hoc analysis of the randomised, controlled PREVA study. Gaul C; Magis D; Liebler E; Straube A J Headache Pain; 2017 Dec; 18(1):22. PubMed ID: 28197844 [TBL] [Abstract][Full Text] [Related]
31. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study. Lipton RB; Munjal S; Brand-Schieber E; Rapoport AM Headache; 2018 May; 58(5):676-687. PubMed ID: 29878341 [TBL] [Abstract][Full Text] [Related]
32. Review of non-invasive vagus nerve stimulation (gammaCore): efficacy, safety, potential impact on comorbidities, and economic burden for episodic and chronic cluster headache. Mwamburi M; Liebler EJ; Tenaglia AT Am J Manag Care; 2017 Nov; 23(17 Suppl):S317-S325. PubMed ID: 29144717 [TBL] [Abstract][Full Text] [Related]
33. Noninvasive Transcutaneous Vagus Nerve Stimulation Decreases Whole Blood Culture-Derived Cytokines and Chemokines: A Randomized, Blinded, Healthy Control Pilot Trial. Lerman I; Hauger R; Sorkin L; Proudfoot J; Davis B; Huang A; Lam K; Simon B; Baker DG Neuromodulation; 2016 Apr; 19(3):283-90. PubMed ID: 26990318 [TBL] [Abstract][Full Text] [Related]
34. Non-invasive vagus nerve stimulation for treatment of cluster headache: early UK clinical experience. Marin J; Giffin N; Consiglio E; McClure C; Liebler E; Davies B J Headache Pain; 2018 Nov; 19(1):114. PubMed ID: 30470171 [TBL] [Abstract][Full Text] [Related]
35. Non-invasive vagus nerve stimulation for PREVention and Acute treatment of chronic cluster headache (PREVA): A randomised controlled study. Gaul C; Diener HC; Silver N; Magis D; Reuter U; Andersson A; Liebler EJ; Straube A; Cephalalgia; 2016 May; 36(6):534-46. PubMed ID: 26391457 [TBL] [Abstract][Full Text] [Related]
36. Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM). Kuruvilla DE; Mann JI; Tepper SJ; Starling AJ; Panza G; Johnson MAL Sci Rep; 2022 Mar; 12(1):5110. PubMed ID: 35332216 [TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: long-term results from a randomized, multicenter, double-blinded, controlled study. Dodick DW; Silberstein SD; Reed KL; Deer TR; Slavin KV; Huh B; Sharan AD; Narouze S; Mogilner AY; Trentman TL; Ordia J; Vaisman J; Goldstein J; Mekhail N Cephalalgia; 2015 Apr; 35(4):344-58. PubMed ID: 25078718 [TBL] [Abstract][Full Text] [Related]
38. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks. Tepper SJ; Cady RK; Silberstein S; Messina J; Mahmoud RA; Djupesland PG; Shin P; Siffert J Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016 [TBL] [Abstract][Full Text] [Related]
39. Update on noninvasive neuromodulation for migraine treatment-Vagus nerve stimulation. Schoenen J; Ambrosini A Prog Brain Res; 2020; 255():249-274. PubMed ID: 33008508 [TBL] [Abstract][Full Text] [Related]
40. Non-invasive neuromodulation in the acute treatment of migraine: a systematic review and meta-analysis of randomized controlled trials. Clark O; Mahjoub A; Osman N; Surmava AM; Jan S; Lagman-Bartolome AM Neurol Sci; 2022 Jan; 43(1):153-165. PubMed ID: 34698941 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]